The Administration for Strategic Preparedness and Response May 16 announced it is launching four pharmaceutical manufacturing ...

While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

If mishandled, this move could undermine public trust in the FDA and squander a once-in-a-generation opportunity to lead the ...

AdvaMed, the MedTech Association, released its AI Policy Roadmap (the Roadmap) outlining policy priorities for Congress and the U.S. Food and Drug Administration (FDA).

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

We recently published a list of the 10 Most Popular AI Stocks to Avoid Now. In this article, we are going to take a look at ...

GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

The U.S. Digital Therapeutics Market encompasses software-driven solutions designed to prevent, manage, and treat medical conditions and diseases through evidence-based, clinically validated digital ...

"By combining internal, pre-clinical experimental data, with real-world data from Tempus on its AI-powered platform, we can profoundly deepen our understanding of cancer biology and accelerate our ...